Alemtuzumab induction therapy in HIV-positive renal transplant recipients

AIDS. 2017 Apr 24;31(7):1047-1048. doi: 10.1097/QAD.0000000000001413.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Alemtuzumab / administration & dosage*
  • Graft vs Host Disease / prevention & control*
  • HIV Infections / complications*
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Kidney Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Renal Insufficiency / surgery*
  • Transplant Recipients
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Alemtuzumab